ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published: November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like NIH awards multi-million grant for groundbreaking organ transplantation research September 6, 2024 AI model predicts Alzheimer’s progression with new insights into racial and sex-based disparities November 5, 2024 Study reveals high prevalence of chronic traumatic encephalopathy among former NFL players August 25, 2026
AI model predicts Alzheimer’s progression with new insights into racial and sex-based disparities November 5, 2024
Study reveals high prevalence of chronic traumatic encephalopathy among former NFL players August 25, 2026